Atlas Trials

Effect of Ozone on Airway Inflammation in Allergic Asthmatics Treated With Omalizumab

Clinical trial NCT00287378 · TERMINATED

Trial details

NCT number
NCT00287378
Sponsor
University of North Carolina, Chapel Hill
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
AsthmaAllergy
Start date
2006-03-01
Primary completion
2007-07-01
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.